Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 8604723, 9 pages
https://doi.org/10.1155/2017/8604723
Research Article

Combination of Neuroprotective and Regenerative Agents for AGE-Induced Retinal Degeneration: In Vitro Study

Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine, Inohana 1-8-1, Chuo-ku, Chiba, Chiba Prefecture 260-8670, Japan

Correspondence should be addressed to Toshiyuki Oshitari; moc.loa@iirat

Received 2 December 2016; Revised 27 February 2017; Accepted 4 April 2017; Published 9 May 2017

Academic Editor: Yoshifumi Saisho

Copyright © 2017 Guzel Bikbova et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. F. Passos, G. Saretzki, S. Ahmed et al., “Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence,” PLoS Biology, vol. 5, no. 5, article e110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. T. B. L. Kirkwood, “Understanding the odd science of aging,” Cell, vol. 120, no. 4, pp. 437–447, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Jerums, S. Panagiotopoulos, J. Forbes, T. Osicka, and M. Cooper, “Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease,” Archives of Biochemistry and Biophysics, vol. 419, no. 1, pp. 55–62, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. H.-P. Hammes, S. Martin, K. Federlin, K. Geisen, and M. Brownlee, “Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 88, no. 24, pp. 11555–11558, 1991. View at Publisher · View at Google Scholar · View at Scopus
  5. T. Soulis-Liparota, M. Cooper, D. Papazoglou, B. Clarke, and G. Jerums, “Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat,” Diabetes, vol. 40, no. 10, pp. 1328–1334, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Nakamura, Z. Makita, S. Ishikawa et al., “Progression of nephropathy in spontaneous diabetic rats is prevented by OPB-9195, a novel inhibitor of advanced glycation,” Diabetes, vol. 46, no. 5, pp. 895–899, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. Z. Q. Gao, C. Yang, Y. Y. Wang et al., “RAGE upregulation and nuclear factor-kappaB activation associated with ageing rat cardiomyocyte dysfunction,” General Physiology and Biophysics, vol. 27, no. 3, pp. 152–158, 2008. View at Google Scholar
  8. G. Bikbova, T. Oshitari, T. Baba, and S. Yamamoto, “Altered expression of NF-κB and SP1 after exposure to advanced glycation end-products and effects of neurotrophic factors in AGEs exposed rat retinas,” Journal of Diabetes Research, vol. 2015, Article ID 543818, 11 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. U. Oltmanns, R. Issa, M. B. Sukkar, M. John, and K. F. Chung, “Role of c-jun N-terminal kinase in the induced release of GM-CSF, RANTES and IL-8 from human airway smooth muscle cells,” British Journal of Pharmacology, vol. 139, no. 6, pp. 1228–1234, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Bikvoba, T. Oshitari, T. Baba, and S. Yamamoto, “Mechanisms of neuronal cell death in AGEs exposed retinas—research and literature review,” Current Diabetes Review, In press.
  11. T. Oshitari, N. Fujimoto, and E. Adachi-Usami, “Citicoline has a protective effect on damaged retinal ganglion cells in mouse culture retina,” NeuroReport, vol. 13, no. 16, pp. 2109–2111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophin-4 on endoplasmic reticulum stress-related neuronal apoptosis in diabetic and high glucose exposed rat retinas,” Neuroscience Letters, vol. 501, no. 2, pp. 102–106, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Oshitari, N. Yoshida-Hata, and S. Yamamoto, “Effect of neurotrophic factors on neuronal apoptosis and neurite regeneration in cultured rat retinas exposed to high glucose,” Brain Research, vol. 1346, pp. 43–51, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Oshitari and E. Adachi-Usami, “The effect of caspase inhibitors and neurotrophic factors on damaged retinal ganglion cells,” NeuroReport, vol. 14, no. 2, pp. 289–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Oshitari, S. Yamamoto, N. Hata, and S. Roy, “Mitochondria- and caspase-dependent cell death pathway involved in neuronal degeneration in diabetic retinopathy,” British Journal of Ophthalmology, vol. 92, no. 4, pp. 552–556, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Oshitari, M. Dezawa, S. Okada et al., “The role of c-fos in cell death and regeneration of retinal ganglion cells,” Investigative Ophthalmology and Visual Science, vol. 43, no. 7, pp. 2442–2449, 2002. View at Google Scholar · View at Scopus
  17. T. Oshitari, G. Bikbova, and S. Yamamoto, “Increased expression of phosphorylated c-Jun and phosphorylated c-Jun N-terminal kinase associated with neuronal cell death in diabetic and high glucose exposed rat retinas,” Brain Research Bulletin, vol. 101, pp. 18–25, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. G. Bikbova, T. Oshitari, and S. Yamamoto, “Neurite regeneration in adult rat retinas exposed to advanced glycation end-products and regenerative effects of neurotrophin-4,” Brain Research, vol. 1534, pp. 33–45, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Saver, “Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair,” Reviews in Neurological Diseases, vol. 5, no. 4, pp. 167–177, 2008. View at Google Scholar · View at Scopus
  20. P. Fagone and S. Jackowski, “Phosphatidylcholine and the CDP-choline cycle,” Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, vol. 1831, no. 3, pp. 523–532, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Secades, “Citicoline: pharmacological and clinical review, 2010 update,” Revista de Neurologia, vol. 52, supplement 2, pp. S1–S62, 2011. View at Google Scholar · View at Scopus
  22. A. M. Rao, J. F. Hatcher, and R. J. Dempsey, “Does CDP-choline modulate phospholipase activities after transient forebrain ischemia?” Brain Research, vol. 893, no. 1-2, pp. 268–272, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Alvarez-Sabín and G. C. Román, “The role of citicoline in neuroprotection and neurorepair in ischemic stroke,” Brain Sciences, vol. 23, no. 3, pp. 1395–1414, 2013. View at Publisher · View at Google Scholar
  24. M. Gutiérrez-Fernández, B. Rodríguez-Frutos, B. Fuentes et al., “CDP-choline treatment induces brain plasticity markers expression in experimental animal stroke,” Neurochemistry International, vol. 60, no. 3, pp. 310–317, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Pawar, S. Mumbare, M. Patil, and S. Ramakrishnan, “Effectiveness of the addition of citicoline to patching in the treatment of amblyopia around visual maturity: a randomized controlled trial,” Indian Journal of Ophthalmology, vol. 62, no. 2, pp. 124–129, 2014. View at Publisher · View at Google Scholar · View at Scopus
  26. R. N. Weinreb, T. Aung, and F. A. Medeiros, “The pathophysiology and treatment of glaucoma: a review,” The Journal of the American Medical Association, vol. 311, no. 18, pp. 1901–1911, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. R. M. Adibhatla and J. F. Hatcher, “Citicoline decreases phospholipase A2 stimulation and hydroxyl radical generation in transient cerebral ischemia,” Journal of Neuroscience Research, vol. 73, no. 3, pp. 308–315, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Roberti, L. Tanga, V. Parisi, M. Sampalmieri, M. Centofanti, and G. Manni, “A preliminary study of the neuroprotective role of citicoline eye drops in glaucomatous optic neuropathy,” Indian Journal of Ophthalmology, vol. 62, no. 5, pp. 549–553, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. V. Parisi, M. Centofanti, L. Ziccardi et al., “Treatment with citicoline eye drops enhances retinal function and neural conduction along the visual pathways in open angle glaucoma,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 253, no. 8, pp. 1327–1340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Zerbini, F. Bandello, R. Lattanzio et al., “In vivo Evaluation of Retinal and Choroidal Structure in a Mouse Model of Long-Lasting Diabetes. Effect of Topical Treatment with Citicoline,” Journal of Ocular Diseases and Therapeutics, vol. 3, no. 1, pp. 1–8, 2015. View at Publisher · View at Google Scholar
  31. J. Y. Zhang, Y. F. Diao, H. R. Kim, and D. I. Jin, “Inhibition of endoplasmic reticulum stress improves mouse embryo development,” PLoS ONE, vol. 7, no. 7, Article ID e40433, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Oshitari and S. Roy, “Diabetes: a potential enhancer of retinal injury in rat retinas,” Neuroscience Letters, vol. 390, no. 1, pp. 25–30, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Oyadomari and M. Mori, “Roles of CHOP/GADD153 in endoplasmic reticulum stress,” Cell Death & Differentiation, vol. 11, no. 4, pp. 381–389, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. H. Liu, J. Qian, F. Wang et al., “Expression of two endoplasmic reticulum stress markers, GRP78 and GADD153, in rat retinal detachment model and its implication,” Eye, vol. 24, no. 1, pp. 137–144, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. B. Falsini, G. Larossi, A. Chiaretti et al., “NGF eye-drops topical administration in patients with retinitis pigmentosa, a pilot study,” Journal of Translational Medicine, vol. 14, p. 8, 2016. View at Publisher · View at Google Scholar · View at Scopus